- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced or Metastatic Paraganglioma/ Pheochromocytoma in United Kingdom
Total 1045 results
-
Abramson Cancer Center of the University of PennsylvaniaCompletedUnresectable Paraganglioma | Recurrent Pheochromocytoma | Advanced Metastatic Paraganglioma | Advanced Metastatic Pheochromocytoma | Recurrent Paraganglioma | Unresectable PheochromocytomaUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Adrenal Gland Pheochromocytoma | Metastatic Paraganglioma | Unresectable Adrenal Gland Pheochromocytoma | Unresectable Paraganglioma | Advanced Adrenal Gland Pheochromocytoma | Advanced Paraganglioma | Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8 | Stage...United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Adrenal Gland Pheochromocytoma | Locally Advanced Paraganglioma | Metastatic Paraganglioma | Unresectable Adrenal Gland Pheochromocytoma | Unresectable Paraganglioma | Regional Adrenal Gland PheochromocytomaUnited States
-
University College, LondonAstraZeneca; Cancer Research UKWithdrawnParaganglioma | PhaeochromocytomaUnited Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMetastatic Adrenal Gland Pheochromocytoma | Malignant Adrenal Gland Pheochromocytoma | Malignant ParagangliomaUnited States
-
National Cancer Institute (NCI)TerminatedParaganglioma | Metastatic Adrenal Gland Pheochromocytoma | Recurrent Adrenal Gland Pheochromocytoma | Extra-Adrenal ParagangliomaUnited States, Singapore, Hong Kong
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMetastatic Adrenal Gland Pheochromocytoma | Stage III Thyroid Gland Medullary Carcinoma AJCC v8 | Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 | Locally Advanced Adrenal Gland Pheochromocytoma | Locally Advanced Paraganglioma | Metastatic Paraganglioma | Metastatic Parathyroid Gland Carcinoma and other conditionsUnited States
-
University of Texas Southwestern Medical CenterNo longer availableRelapsed Neuroblastoma | Metastatic PheochromocytomaUnited States
-
Masonic Cancer Center, University of MinnesotaSuspendedRelapsed Neuroblastoma | Metastatic PheochromocytomaUnited States
-
John MarisAvailableNeuroblastoma | Childhood Metastatic PheochromocytomaUnited States
-
AstraZenecaCompletedAdvanced Solid Metastatic TumorUnited Kingdom
-
Advanced Accelerator ApplicationsActive, not recruitingPheochromocytoma | Paraganglioma | Gastroenteropancreatic Neuroendocrine TumorsUnited States, Spain, France, Poland, United Kingdom
-
Taiho Oncology, Inc.TerminatedAdvanced or Metastatic Solid Tumors Irrespective of Gene Alterations | Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating MutationsUnited States, United Kingdom, Austria, France
-
OncoMed Pharmaceuticals, Inc.Celgene CorporationCompletedLocally Advanced or Metastatic Solid TumorsUnited States, United Kingdom
-
Lupin Ltd.CompletedA Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsNRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsUnited Kingdom, Netherlands, Belgium
-
National Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Adrenal Gland Pheochromocytoma | Paraganglioma | Hematopoietic and Lymphatic System NeoplasmUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, China, Spain, Japan, United Kingdom
-
University of California, Los AngelesCompleted
-
Sue O'DorisioAdvanced Accelerator ApplicationsWithdrawnNeuroendocrine Tumors | Pheochromocytoma | ParagangliomaUnited States
-
University of California, San FranciscoApproved for marketingPheochromocytoma | ParagangliomaUnited States
-
Antonio FojoIpsenRecruitingPheochromocytoma | ParagangliomaUnited States
-
Heather WachtelRecruitingPheochromocytoma | ParagangliomaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsUnknownAdvanced and/or Metastatic Solid Organ CancerUnited States
-
University of California, San FranciscoCompletedPheochromocytoma | ParagangliomaUnited States
-
Molecular Insight Pharmaceuticals, Inc.Approved for marketingPheochromocytoma | ParagangliomaUnited States
-
Molecular Insight Pharmaceuticals, Inc.CompletedPheochromocytoma | ParagangliomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMetastatic Cancer or Locally Advanced | Patients Receiving Palliative RadiationUnited States
-
Molecular Insight Pharmaceuticals, Inc.UnknownPheochromocytoma | ParagangliomaUnited States
-
Bristol-Myers SquibbActive, not recruitingAdvanced or Metastatic Solid TumorsUnited States, Spain, Italy, Canada, Germany, United Kingdom, Denmark, Finland
-
Shanghai Miracogen Inc.RecruitingAdvanced Solid Tumors | Advanced or Metastatic Gastric Cancer | Advanced or Metastatic Gastroesophageal Junction CancerUnited States
-
Taiho Oncology, Inc.Active, not recruitingAdvanced or Metastatic Solid Tumor | Advanced or Metastatic Gastric or Gastroesophageal Cancer | Myeloid or Lymphoid Neoplasms (MLN)United States, Spain, Turkey, Hong Kong, Korea, Republic of, Belgium, Japan, Netherlands, France, Germany, Italy, Sweden, United Kingdom, Portugal, Singapore
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Synta Pharmaceuticals Corp.CompletedAdvanced or Metastatic Solid TumorsUnited States
-
DynamiCure BiotechnologyTerminatedAdvanced or Metastatic Solid TumorsUnited States
-
National Cancer Institute (NCI)CompletedPheochromocytoma | ParagangliomaUnited States
-
Columbia UniversityPfizerRecruitingPheochromocytoma | ParagangliomaUnited States
-
Aptose Biosciences Inc.CompletedAdvanced or Metastatic Solid TumoursUnited States
-
Incendia TherapeuticsRecruitingAdvanced or Metastatic Solid TumorsUnited States
-
TakedaTakeda Development Center Americas, Inc.RecruitingUnresectable Locally Advanced or Metastatic CancerSpain, United States, Australia, Canada
-
Nerviano Medical SciencesTerminatedAdvanced/Metastatic Solid TumorsUnited Kingdom, France
-
Erasca, Inc.Active, not recruitingAdvanced or Metastatic Solid TumorsUnited States
-
Hanmi Pharmaceutical Company LimitedRecruitingAdvanced or Metastatic Solid TumorsKorea, Republic of, United States
-
GigaGen, Inc.National Cancer Institute (NCI)RecruitingAdvanced or Metastatic Solid Tumor MalignanciesUnited States
-
Pyrotech Therapeutics, Inc.RecruitingLocally Advanced or Metastatic Solid TumorsUnited States
-
Tallac TherapeuticsRecruitingAdvanced or Metastatic Solid TumorsUnited States, Australia
-
Shanghai Miracogen Inc.RecruitingAdvanced or Metastatic Solid TumorsUnited States, China
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic or Locally Advanced Unresectable Solid TumorsUnited States
-
BayerCompletedAdvanced or Metastatic Solid TumorUnited States, Spain, Korea, Republic of, Belgium, Singapore, Germany
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced or Metastatic Solid MalignanciesUnited States